Cardiac complications in children with Kawasaki disease in our own experience

Ewelina Gowin1, Ilona Małecka, Joanna Stryczyńska-Kazubska

  • 1Department of Family Medicine, Poznan University of Medical Sciences, Poland Specialist Mother and Child Healthcare Facility, Poznan, Poland. ewego@poczta.onet.pl.

Kardiologia Polska
|July 24, 2015
PubMed

Insights

Kawasaki disease, a common cause of acquired heart disease in children, frequently leads to cardiac complications. Early cardiac evaluation and long-term monitoring are crucial for affected children.

Area of Science:

  • Pediatrics
  • Cardiology
  • Infectious Diseases

Background:

  • Kawasaki disease is a leading cause of acquired heart disease in children globally.
  • Incidence varies significantly by region, with higher rates in Japan and lower rates in Europe and the US.
  • Understanding cardiac complications is vital for pediatric health.

Purpose of the Study:

  • To evaluate the spectrum and incidence of cardiac complications in children hospitalized with Kawasaki disease.
  • To assess the diagnostic criteria and outcomes of Kawasaki disease in a Polish pediatric population.

Main Methods:

  • Retrospective analysis of medical records of 30 children diagnosed with Kawasaki disease between 2008-2014.
  • Diagnosis adherence to the American Heart Association criteria.
  • Inclusion of clinical data, laboratory findings, and cardiac assessment results.

Main Results:

  • Cardiac involvement was observed in 60% of patients, with coronary artery abnormalities (dilatation or aneurysms) in 13.3% to 20%.
  • Other cardiac complications included pericarditis (6 patients) and valvular regurgitation (mitral and aortic).
  • 18% of patients experienced multiple cardiac issues; coronary artery dilatation resolved in most cases within a year.

Conclusions:

  • Kawasaki disease necessitates consideration in children with prolonged fever, requiring prompt cardiac evaluation.
  • Regular cardiac monitoring during the acute phase and long-term follow-up are essential for managing cardiovascular sequelae.
  • Implementation of a national reporting system for Kawasaki disease in Poland is recommended to improve surveillance.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
892
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
670
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
579
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
741
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.7K